Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaw-Town Lin

Showing results (321-330 of 327) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 327 results.
The Journal of Antimicrobial Chemotherapy|May 31, 2018
14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trialJyh-Ming Liou, Chieh-Chang Chen, Yu-Jen Fang, et al.
BMJ Open|November 2, 2013
Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesionsYi-Chia Lee, Han-Mo Chiu, Tsung-Hsien Chiang, et al.
Helicobacter|September 22, 2025
Overall and Stratified Accuracies of H. pylori Serology Testing: A Multicenter Study of 8497 Screening-Naïve AdultsMei-Jyh Chen, Yu-Jen Fang, Chien-Chuan Chen, et al.
The Lancet. Gastroenterology & Hepatology|December 22, 2022
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trialJyh-Ming Liou, Xiao-Tao Jiang, Chieh-Chang Chen, et al.
Lancet (London, England)|October 23, 2016
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh-Ming Liou, Yu-Jen Fang, Chieh-Chang Chen, et al.
Gut|October 2, 2020
Screening and eradication of <i>Helicobacter pylori</i> for gastric cancer prevention: the Taipei global consensusJyh-Ming Liou, Peter Malfertheiner, Yi-Chia Lee, et al.
Gut|September 5, 2025
Screening and eradication of <i>Helicobacter pylori f</i>or gastric cancer prevention: Taipei Global Consensus IIJyh-Ming Liou, Peter Malfertheiner, Tzu-Chan Hong, et al.
Pageof 33

Showing results (321-330 of 327) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 327 results.
The Journal of Antimicrobial Chemotherapy|May 31, 2018
14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trialJyh-Ming Liou, Chieh-Chang Chen, Yu-Jen Fang, et al.
BMJ Open|November 2, 2013
Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesionsYi-Chia Lee, Han-Mo Chiu, Tsung-Hsien Chiang, et al.
Helicobacter|September 22, 2025
Overall and Stratified Accuracies of H. pylori Serology Testing: A Multicenter Study of 8497 Screening-Naïve AdultsMei-Jyh Chen, Yu-Jen Fang, Chien-Chuan Chen, et al.
The Lancet. Gastroenterology & Hepatology|December 22, 2022
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trialJyh-Ming Liou, Xiao-Tao Jiang, Chieh-Chang Chen, et al.
Lancet (London, England)|October 23, 2016
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialJyh-Ming Liou, Yu-Jen Fang, Chieh-Chang Chen, et al.
Gut|October 2, 2020
Screening and eradication of <i>Helicobacter pylori</i> for gastric cancer prevention: the Taipei global consensusJyh-Ming Liou, Peter Malfertheiner, Yi-Chia Lee, et al.
Gut|September 5, 2025
Screening and eradication of <i>Helicobacter pylori f</i>or gastric cancer prevention: Taipei Global Consensus IIJyh-Ming Liou, Peter Malfertheiner, Tzu-Chan Hong, et al.
Pageof 33